Other factors associated with overall mortality
| Outcome . | HR (95% CI) . | P value . | |
|---|---|---|---|
| Overall mortality | |||
| Recipient age, years | <.001 | ||
| <18 | 1.00 | ||
| 18 to 45 | 1.42 (1.29-1.57) | <.001 | |
| >45 | 1.83 (1.64-2.05) | <.001 | |
| Recipient cytomegalovirus serostatus | <.001 | ||
| Seronegative | 1.00 | ||
| Seropositive | 1.24 (1.15-1.34) | <.001 | |
| Performance score | <.001 | ||
| 90 to 100 | 1.00 | ||
| <90 | 1.27 (1.19-1.37) | <.001 | |
| Disease | <.001 | ||
| Acute leukemia | 1.00 | ||
| Chronic myeloid leukemia | 0.86 (0.78-0.94) | .001 | |
| Myelodysplastic syndrome | 0.79 (0.70-0.88) | <.001 | |
| Disease status at transplantation | <.001 | ||
| 1st CR/CP/RA | 1.00 | ||
| 2nd CR/CP/AP | 1.29 (1.19-1.39) | <.001 | |
| Relapse/blast phase/RAEB | 2.10 (1.93-2.27) | <.001 | |
| Transplant period | <.001 | ||
| 2004 to 2006 | 1.00 | ||
| 1988 to 2003 | 1.22 (1.12-1.33) | <.001 |
| Outcome . | HR (95% CI) . | P value . | |
|---|---|---|---|
| Overall mortality | |||
| Recipient age, years | <.001 | ||
| <18 | 1.00 | ||
| 18 to 45 | 1.42 (1.29-1.57) | <.001 | |
| >45 | 1.83 (1.64-2.05) | <.001 | |
| Recipient cytomegalovirus serostatus | <.001 | ||
| Seronegative | 1.00 | ||
| Seropositive | 1.24 (1.15-1.34) | <.001 | |
| Performance score | <.001 | ||
| 90 to 100 | 1.00 | ||
| <90 | 1.27 (1.19-1.37) | <.001 | |
| Disease | <.001 | ||
| Acute leukemia | 1.00 | ||
| Chronic myeloid leukemia | 0.86 (0.78-0.94) | .001 | |
| Myelodysplastic syndrome | 0.79 (0.70-0.88) | <.001 | |
| Disease status at transplantation | <.001 | ||
| 1st CR/CP/RA | 1.00 | ||
| 2nd CR/CP/AP | 1.29 (1.19-1.39) | <.001 | |
| Relapse/blast phase/RAEB | 2.10 (1.93-2.27) | <.001 | |
| Transplant period | <.001 | ||
| 2004 to 2006 | 1.00 | ||
| 1988 to 2003 | 1.22 (1.12-1.33) | <.001 |